These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 17761373)
21. Pharmacokinetics of melphalan in myeloma patients undergoing an autograft. Nath CE; Shaw PJ; Trotman J; Zeng L Bone Marrow Transplant; 2007 Oct; 40(7):707-8. PubMed ID: 17680022 [No Abstract] [Full Text] [Related]
22. The evolution and impact of therapy in multiple myeloma. Laubach JP; Richardson PG; Anderson KC Med Oncol; 2010 Jun; 27 Suppl 1():S1-6. PubMed ID: 20169425 [TBL] [Abstract][Full Text] [Related]
23. Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure. Spencer A; Prince HM; Roberts AW; Prosser IW; Bradstock KF; Coyle L; Gill DS; Horvath N; Reynolds J; Kennedy N J Clin Oncol; 2009 Apr; 27(11):1788-93. PubMed ID: 19273705 [TBL] [Abstract][Full Text] [Related]
24. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation. Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045 [TBL] [Abstract][Full Text] [Related]
25. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation. Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH; Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634 [TBL] [Abstract][Full Text] [Related]
27. Lenalidomide in multiple myeloma. Thomas SK; Richards TA; Weber DM Best Pract Res Clin Haematol; 2007 Dec; 20(4):717-35. PubMed ID: 18070715 [TBL] [Abstract][Full Text] [Related]
28. Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma. Martino M; Olivieri A; Offidani M; Vigna E; Moscato T; Fedele R; Montanari M; Console G; Gentile M; Messina G; Irrera G; Morabito F Expert Opin Investig Drugs; 2013 May; 22(5):619-34. PubMed ID: 23550793 [TBL] [Abstract][Full Text] [Related]
29. The changing landscape of myeloma therapy. Cavo M; Baccarani M N Engl J Med; 2006 Mar; 354(10):1076-8. PubMed ID: 16525146 [No Abstract] [Full Text] [Related]
30. Frontline treatment in elderly patients with multiple myeloma. Facon T; San Miguel J; Mateos MV; Hulin C Semin Hematol; 2009 Apr; 46(2):133-42. PubMed ID: 19389497 [TBL] [Abstract][Full Text] [Related]
31. Stem cell transplantation for multiple myeloma: current status and future directions. Caldera H; Giralt S Curr Hematol Rep; 2004 Jul; 3(4):249-56. PubMed ID: 15217554 [TBL] [Abstract][Full Text] [Related]
32. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma. Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425 [TBL] [Abstract][Full Text] [Related]
33. Multiple myeloma--an update on diagnosis and treatment. Caers J; Vande broek I; De Raeve H; Michaux L; Trullemans F; Schots R; Van Camp B; Vanderkerken K Eur J Haematol; 2008 Nov; 81(5):329-43. PubMed ID: 18637123 [TBL] [Abstract][Full Text] [Related]
34. Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14). Hundemer M; Klein U; Hose D; Raab MS; Cremer FW; Jauch A; Benner A; Heiss C; Moos M; Ho AD; Goldschmidt H Bone Marrow Transplant; 2007 Dec; 40(11):1033-7. PubMed ID: 17891186 [TBL] [Abstract][Full Text] [Related]
35. Presentation and risk stratification--improving prognosis for patients with multiple myeloma. Lonial S Cancer Treat Rev; 2010 May; 36 Suppl 2():S12-7. PubMed ID: 20472183 [TBL] [Abstract][Full Text] [Related]